Tag: Prescription Drugs
Olpasiran Leads to Significant Reduction in Oxidized Phospholipids
Olpasiran leads to significant and sustained reduction in OxPL on apolipoprotein B
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
Lower risk for COPD exacerbations seen with SGLT-2 inhibitors and GLP-1 receptor agonists, but not with DPP-4 inhibitors
Anifrolumab Tied to Less Organ Damage for Patients With Lupus
Lower likelihood seen for experiencing increase in Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index
Talazoparib + Enzalutamide Tied to Improved Overall Survival in Metastatic Prostate Cancer
Talazoparib + enzalutamide linked to improved survival for patients with mCRPC unselected for HRR gene alterations
De-Escalating DAPT to Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
Lower risk for bleeding without increase in ischemic events seen for patients with acute coronary syndrome
ASA: Intra-Arterial Tenecteplase Beneficial for Large Vessel Occlusion
Improved likelihood of excellent outcome seen with intra-arterial tenecteplase after successful endovascular recanalization
ASA: Alteplase Ups Outcomes at 4.5 to 24 Hours After Symptom Onset in Acute...
Significantly more patients with acute ischemic stroke achieved primary outcome of 0 or 1 on modified Rankin scale at 90 days
Ischemic Stroke Risk Higher With Use of Contemporary Hormonal Contraceptives
Increased risk seen with use of combined pill, progestin-only pills, combined vaginal ring, patch, and progestin-only implant
Offspring of Women With Epilepsy Experience Decreased Bone Metabolism
Exposure to more antiseizure medications also tied to additional issues
Use of Secondary CVD Prevention Medications Low in Most Countries
Use of one or more classes of medications for secondary CVD prevention peaked at 43.1 percent, decreased to 31.3 percent
